Bamlanivimab

• Sotrovimab COVID-19 drug: A look at how it’s being used to combat Omicron in Canada

  Sotrovimab is the only monoclonal antibody treatment that appears to be effective against the Omicron variant, according to medical experts.

  Health

  Jan 2, 2022
  
• B.C. to start clinical trials for previously rejected COVID-19 treatment

  Vancouver-based biotech firm AbCellera has donated $1 million to the province to support the clinical trials.

  Health

  Feb 9, 2021
  
• Advertisement
• Antibody can prevent COVID-19 infection in nursing, LTC homes: drugmaker Eli Lilly

  The study, which was conducted with the National Institutes of Health, is the first major one to show such a treatment may prevent illness in a group devastated by the pandemic.

  Health

  Jan 21, 2021
• Advertisement
• Canada secures 26K doses of coronavirus antibody treatment – here’s how it works

  Bamlanivimab is the first coronavirus antibody treatment to be approved in Canada.

  Canada

  Nov 24, 2020